Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements.

Clicks: 384
ID: 77832
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #3 of 86 articles by views in therapeutic advances in musculoskeletal disease

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In this work, we aimed to establish a clinical target in the management of knee osteoarthritis (KOA) and to propose good clinical practice (GCP) statements for carrying out a treat-to-target strategy.A steering committee of seven experts had formulated a provisional set of recommendations that were exposed for discussion and modification to a technical expert panel (TEP) of 25 multidisciplinary experts from Europe, North America, South America and Asia. The level of evidence and strength of each recommendation was discussed. The TEP formulated overarching principles and GCP statements based on the level of agreement for each item with a vote using a 10-point numerical scale.Two overarching principles and 10 GCP statements were formulated by the TEP. These GCP statements suggest: treatment should achieve clinical improvement bringing the patient to the Patient Acceptable Symptom State (PASS); pharmacological and nonpharmacological treatment should begin as early as possible, with an early diagnosis of symptomatic KOA; the patient should be evaluated every 3-6 months; risk factors of KOA progression should be identified and managed with patients at the beginning of the treatment and monitored regularly; treatment should be adapted according to patient phenotype and disease severity; healthy lifestyle must be promoted and monitored. The level of agreement average ranged from 8.7 to 9.6 on scale.The proposed overarching principles and GCP statements have the aim of involving patients, general practitioners and multidisciplinary specialists in sharing a therapeutic treat-to-target strategy for KOA management based on the best evidence and expert opinions.
Reference Key
migliore2019treattotargettherapeutic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Migliore, Alberto;Gigliucci, Gianfranco;Alekseeva, Liudmila;Avasthi, Sachin;Bannuru, Raveendhara R;Chevalier, Xavier;Conrozier, Thierry;Crimaldi, Sergio;Damjanov, Nemanja;de Campos, Gustavo Constantino;Diracoglu, Demirhan;Herrero-Beaumont, Gabriel;Iolascon, Giovanni;Ionescu, Ruxandra;Isailovic, Natasa;Jerosch, Jörg;Lains, Jorge;Maheu, Emmanuel;Makri, Souzi;Martusevich, Natalia;Matucci Cerinc, Marco;Micu, Mihaela;Pavelka, Karel;Petrella, Robert J;Tarantino, Umberto;Raman, Raghu;
Journal therapeutic advances in musculoskeletal disease
Year 2019
DOI
10.1177/1759720X19893800
URL
Keywords
osteoarthritis treatment knee osteoarthritis nsaids outcome research

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.